Developing Therapeutics That Teach the Body to Heal Itself
Our team personally cares about the people we serve. We make progress every day to end suffering and premature death from serious human diseases. The Newsletter is one quick way to keep track of AGT™ advancements on all its programs and other events happening at the company. We look forward to keeping you up to date on our mission.
Our team personally cares about the people we serve. We make progress every day to end suffering and premature death from serious human diseases. The Newsletter is one quick way to keep track of AGT™ advancements on all its programs and other events happening at the company. We look forward to keeping you up to date on our mission.
Clinical Trial Progress Update The analytic treatment interruption (ATI) protocol is generating important immunological data. We are currently gathering and analyzing data from five out of the seven clinical... [Read More]
Exciting HIV Clinical Trial Update American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals. “This is a critical step in our mission to cure HIV... [Read More]...
HIV Program Treatment Withdrawal Safety and efficacy blood markers have been recorded in the Phase 1 human trial for AGT’s HIV cure. We expect the antiretroviral treatment withdrawal studies to... [Read More]
HIV Program Update Five for Five! American Gene Technologies (AGT) announced that it has reached another important milestone in its HIV cure program. Five participants were treated with AGT103-T and... [Read More]
HIV Program Update Enrolled First Cohort Since our last Newsletter, AGT has enrolled its first cohort of six participants in its Phase 1 study of AGT103-T against HIV. Updates on... [Read More]
We’ve achieved a number of significant milestones this quarter, including the Food and Drug Administration (FDA) clearance to begin Phase 1 of our HIV cure program. The excitement hasn’t only been... [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
